Homburger houses a broad offering which often advises on cross-border merger control, financing, and patent enforcement mandates. The team notably assists Novartis, Biocorp Holding, and Catalent. Daniel Häusermann stands out due to his broad experience in equity capital markets transactions, and both public and private M&A, while Andri Hess often assists clients with patent litigation and contractual IP issues. Richard Stäuber is well-known for his vast knowledge of merger control and competition investigation issues, with a strong focus on distribution arrangements.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Catalent
- Novartis
- Roche
- ADC Therapeutics
- Santhera
- Biocorp
- Addex Therapeutics
- Sonic Healthcare
- Sandoz
- Eli Lilly
Highlight-Mandate
- Representing Catalent in Swiss merger control proceedings related to its USD 16.5 bn acquisition by Novo Holdings.
- Advised Novartis on the divestment of Life Science Park Rhine Valley to GETEC.
- Representing Novartis in enforcing patents against generic JADENU (deferasirox) products.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Daniel Häusermann; Andri Hess; Richard Stäuber